Matt Zemon is the Co-founder and CEO of HAPPŸŸ, a mental wellness company focused on psychedelic-assisted ketamine therapy. In his role, he leads the company’s vision to expand access to safe, evidence-based psychedelic-assisted ketamine therapy through telemedicine. He also oversees clinical quality, technology innovation, and integrative care programs that blend neuroscience, mindfulness, and digital tools. He is the author of multiple books, including Psychedelics for Everyone, Beyond the Trip, and The Veteran’s Guide to Psychedelics. As a leader in psychedelic wellness, Matt consults with clinicians and spiritual practitioners to integrate psychedelic protocols into thoughtful healing frameworks.

Psychedelics are transitioning from underground traditions into mainstream clinical use, sparking both excitement and debate. How do these medicines hold psychosocial and spiritual significance that modern practices should embrace?

Psychedelic wellness leader Matt Zemon argues that while clinical research is critical, the vast majority of psychedelic use occurs outside medical models. He highlights the role of community, integration, and spiritual connection in healing. Rather than relying on sterile clinical settings, Matt advocates for intentional, compassionate spaces that nurture meaningful transformation. He maintains that although these medicines are catalysts for change, they are not standalone cures.

In this episode of Living Medicine, Dr. Sandy Newes sits down with Matt Zemon, Co-founder and CEO of HAPPŸŸ, to discuss the intersection of science, spirituality, and community in psychedelic work. Matt shares how group settings reinforce interconnectedness, how psychedelics help people align with themselves, and how ketamine can foster transformation and spiritual experiences.